Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Nepal, a small country in the southern part of Asia (figures 1 and 2), is well known over the world for its magnificent natural beauty. Roughly about half the size of the United Kingdom (about 150 000 square kilometres), its rich geography ranges from the hot and humid tropics of the Southern Terai plains (figure 3) adjoining Northern India, to the high mountain range in the north adjoining Tibet, China. Perhaps Nepal’s best-known natural landmark is Mount Everest, the world’s tallest mountain at 8848 m (figure 4). Nepal is also the birthplace of Gautama Buddha, the founding father of the modern Buddhist philosophy (figure 5).
Despite its rich natural resources (figures 6–9) and several hundred years of cultural heritage, hidden among its majestic glories lies the poignant reality of challenges of providing good medical care in one of the least developed countries of the world. As in any other third-world country grappling with the processes of westernisation, stroke is common in Nepal and appears to increase every year. But Nepal has almost none of the skilled manpower and well-equipped facilities needed to deal with this common problem. For a total population of over 30 million, there are fewer than 20 trained neurologists and only a single stroke neurologist—almost all of them concentrated in the capital city of Kathmandu, with its population of …
Contributors The author is solely responsible for the design, draft, revision and final approval of the work. The author agrees to be accountable for all aspects of the work.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Map disclaimer The depiction of boundaries on the map(s) in this article does not imply the expression of any opinion whatsoever on the part of BMJ (or any member of its group) concerning the legal status of any country, territory, jurisdiction or area or of its authorities. The map(s) are provided without any warranty of any kind, either express or implied.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Commissioned. Externally peer reviewed by Colin Mumford, Edinburgh, UK and David Simpson, Edinburgh, UK.
Read the full text or download the PDF:
Other content recommended for you
- Management soon after a stroke
- The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke
- Blood pressure management in acute stroke
- Recent progress in drug treatment for acute stroke
- Management of acute ischemic stroke
- Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases
- Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging
- European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion
- What causes intracerebral bleeding after thrombolysis for acute ischaemic stroke? Recent insights into mechanisms and potential biomarkers
- Antithrombotic therapy for cerebrovascular disorders